Development of new poly(ADP-ribose) polymerase (PARP) inhibitors in ovarian cancer: Quo Vadis?

Epithelial ovarian cancer (EOC) is the fifth leading cause of cancer mortality among women, potentially due to ineffectiveness of screening tests for early detection. Patients typically present with advanced disease at diagnosis, whereas, up to 80% relapse and the estimated median progression-free s...

全面介紹

Na minha lista:
書目詳細資料
發表在:Ann Transl Med
Main Authors: Boussios, Stergios, Moschetta, Michele, Karihtala, Peeter, Samartzis, Eleftherios P., Sheriff, Matin, Pappas-Gogos, George, Ozturk, Mehmet Akif, Uccello, Mario, Karathanasi, Afroditi, Tringos, Michail, Rassy, Elie, Pavlidis, Nicholas
格式: Artigo
語言:Inglês
出版: AME Publishing Company 2020
主題:
Review Article on Ovarian Cancer: State of the Art and Perspectives of Clinical Research
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC7812175/
https://ncbi.nlm.nih.gov/pubmed/33490218
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2020.03.156
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍